Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Carriero, Maria Vincenza ^a   Bifulco, Katia ^a   Longanesi Cattani, Immacolata ^a   Masucci, Maria Teresa ^a   De Chiara, Annarosaria ^a   Fazioli, Flavio ^a   Di Carluccio, Gioconda ^a   Pirozzi, Giuseppe ^a   Gallo, Michele ^a   La Rocca, Antonello ^a   Apice, Gaetano ^a   Rocco, Gaetano ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PEPTIDE DERIVATIVE; RERF PEPTIDE; SOLUBLE UROKINASE RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CHONDROSARCOMA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL CULTURE;

EID: 79952212065     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/842842     Document Type: Article

References (33)

1. Bove J. V. M. G., Hogendoorn P. C. W., Wunder J. S., Alman B. A., Cartilage tumours and bone development: molecular pathology and possible therapeutic targets Nature Reviews Cancer 2010 10 7 481 488
2. Giuffrida A. Y., Burgueno J. E., Koniaris L. G., Gutierrez J. C., Duncan R., Scully S. P., Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database Journal of Bone and Joint Surgery-Series A 2009 91 5 1063 1072
3. Fiorenza F., Abudu A., Grimer R. J., Carter S. R., Tillman R. M., Ayoub K., Mangham D. C., Davies A. M., Risk factors for survival and local control (Pubitemid 34105631)
4. Ayala G., Liu C., Nicosia R., Horowitz S., Lackman R., Microvasculature and VEGF expression in cartilaginous tumors Human Pathology 2000 31 3 341 346 (Pubitemid 30161353)
5. Gelderblom H., Hogendoorn P. C. W., Dijkstra S. D., Van Rijswijk C. S., Krol A. D., Taminiau A. H. M., Bove J. V. M. G., The clinical approach towards chondrosarcoma Oncologist 2008 13 3 320 329 (Pubitemid 351679908)
6. Duffy M. J., Duggan C., The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer Clinical Biochemistry 2004 37 7 541 548 (Pubitemid 38845017)
7. Mondino A., Blasi F., uPA and uPAR in fibrinolysis, immunity and pathology Trends in Immunology 2004 25 8 450 455 (Pubitemid 38951087)
8. Pillay V., Dass C. R., Choong P. F. M., The urokinase plasminogen activator receptor as a gene therapy target for cancer Trends in Biotechnology 2007 25 1 33 39 (Pubitemid 46001467)
9. Binder B. R., Mihaly J., Prager G. W., uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view Thrombosis and Haemostasis 2007 97 3 336 342 (Pubitemid 46437793)
10. Pepper M. S., Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 7 1104 1117 (Pubitemid 34215137)
11. Smith H. W., Marshall C. J., Regulation of cell signalling by uPAR Nature Reviews Molecular Cell Biology 2010 11 1 23 36
12. Carriero M. V., Franco P., Del Vecchio S., Massa O., Botti G., D'Aiuto G., Stoppelli M. P., Salvatore M., Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies Cancer Research 1994 54 20 5445 5454 (Pubitemid 24336039)
13. Dan K., Behrendt N., Hyer-Hansen G., Johnsen M., Lund L. R., Ploug M., Rmer J., Plasminogen activation and cancer Thrombosis and Haemostasis 2005 93 4 676 681 (Pubitemid 40485402)
14. Rasch M. G., Lund I. K., Almasi C. E., Hoyer-Hansen G., Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer Frontiers in Bioscience 2008 13 6752 6762
15. Ploug M., Ellis V., Structure-function relationships in the receptor for urokinase-type plasminogen activator: comparison to other members of the Ly-6 family and snake venom -neurotoxins FEBS Letters 1994 349 2 163 168
16. Resnati M., Pallavicini I., Wang J. M., Oppenheim J., Serhan C. N., Romano M., Blasi F., The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proceedings of the National Academy of Sciences of the United States of America 2002 99 3 1359 1364 (Pubitemid 34136498)
17. Gargiulo L., Longanesi-Cattani I., Bifulco K., Franco P., Raiola R., Campiglia P., Grieco P., Peluso G., Stoppelli M. P., Carriero M. V., Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide Journal of Biological Chemistry 2005 280 26 25225 25232 (Pubitemid 40934616)
18. Barinka C., Parry G., Callahan J., Shaw D. E., Kuo A., Bdeir K., Cines D. B., Mazar A., Lubkowski J., Structural basis of interaction between urokinase-type plasminogen activator and its receptor Journal of Molecular Biology 2006 363 2 482 495 (Pubitemid 44472493)
19. Selleri C., Montuori N., Ricci P., Visconte V., Baiano A., Carriero M. V., Rotoli B., Rossi G., Ragno P., In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer Cancer Research 2006 66 22 10885 10890 (Pubitemid 44876986)
20. Carriero M. V., Longanesi-Cattani I., Bifulco K., Maglio O., Lista L., Barbieri A., Votta G., Masucci M. T., Arra C., Franco R., De Rosa M., Stoppelli M. P., Pavone V., Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis Molecular Cancer Therapeutics 2009 8 9 2708 2717
21. Sidenius N., Blasi F., The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy Cancer and Metastasis Reviews 2003 22 2-3 205 222 (Pubitemid 36561058)
22. Heni E., Borgfeldt C., Christensen IB. J., Cassln B., Hyer-Hansen G., Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer Clinical Cancer Research 2008 14 18 5785
23. Shariat S. F., Roehrborn C. G., McConnell J. D., Park S., Alam N., Wheeler T. M., Slawin K. M., Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis Journal of Clinical Oncology 2007 25 4 349 355 (Pubitemid 350002982)
24. Sidenius N., Sier C. F. M., Blasi F., Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo FEBS Letters 2000 475 1 52 56 (Pubitemid 30331077)
25. Taubert H., Wrl P., Greither T., Kappler M., Bache M., Lautenschlger C., Fssel S., Meye A., Eckert A. W., Holzhausen H. J., Magdolen V., Kotzsch M., Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients British Journal of Cancer 2010 102 4 731 737
26. Antonescu C. R., Ladanyi M., Pathology and Genetics of Tumors of Soft and Bone 2002 Lyon, France IARC Press World Health Organization Classification of Tumors
27. Silvestri I., Cattani I. L., Franco P., Pirozzi G., Botti G., Stoppelli M. P., Carriero M. V., Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating v 5 vitronectin receptor cell surface expression International Journal of Cancer 2002 102 6 562 571 (Pubitemid 35334462)
28. Bifulco K., De Chiara A., Fazioli F., Longanesi-Cattani I., Cantelmo A. R., Tirino V., Apice G., Rocco G., Lombardi M. L., Carriero M. V., Cell invasiveness in sarcomas: a possibly useful clinical correlation Tumori 2008 94 4 505 510
29. Carriero M. V., Del Vecchio S., Capozzoli M., Franco P., Fontana L., Zannetti A., Botti G., D'Aiuto G., Salvatore M., Stoppelli M. P., Urokinase receptor interacts with (v) vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer Cancer Research 1999 59 20 5307 5314 (Pubitemid 29503999)
30. Bifulco K., Longanesi-Cattani I., Gala M., The soluble form of urokinase receptor promotes angiogenesis through its SER(88) -ARG-SER-ARG-TYR(92) chemotactic sequence Journal of Thrombosis and Haemostasis 2010 8 12 2789 2799
31. Montuori N., Bifulco K., Carriero M. V., La Penna C., Visconte V., Alfano D., Pesapane A., Rossi F. W., Salzano S., Rossi G., Ragno P., The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cellular and Molecular Life Sciences. In press
32. Selleri C., Montuori N., Ricci P., Visconte V., Carriero M. V., Sidenius N., Serio B., Blasi F., Rotoli B., Rossi G., Ragno P., Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization Blood 2005 105 5 2198 2205 (Pubitemid 40731813)
33. Albini A., Iwamoto Y., Kleinman H. K., A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Research 1987 47 12 3239 3245 (Pubitemid 17082655